Furthermore, we described the mechanism by which IL-6 mediates tumor immunosuppression by focusing on metabolic competition between T-cells and tumor cells via hypoxia-pseudohypoxia-mediated HIF1α activation. The gene discussed is IL6; the disease is neoplasm.